Free Trial

Histogen (HSTO) Competitors

Histogen logo
$0.0003 0.00 (0.00%)
As of 07/24/2025

HSTO vs. HEPA, BPTSY, VRPX, VIRX, NCNA, BON, CAPS, MYMD, VINC, and UPC

Should you be buying Histogen stock or one of its competitors? The main competitors of Histogen include Hepion Pharmaceuticals (HEPA), Biophytis (BPTSY), Virpax Pharmaceuticals (VRPX), Viracta Therapeutics (VIRX), NuCana (NCNA), Bon Natural Life (BON), Capstone Therapeutics (CAPS), MyMD Pharmaceuticals (MYMD), Vincerx Pharma (VINC), and Universe Pharmaceuticals (UPC). These companies are all part of the "pharmaceutical products" industry.

Histogen vs. Its Competitors

Histogen (NASDAQ:HSTO) and Hepion Pharmaceuticals (NASDAQ:HEPA) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, analyst recommendations, dividends, valuation, risk, institutional ownership and earnings.

17.2% of Hepion Pharmaceuticals shares are held by institutional investors. 3.3% of Histogen shares are held by company insiders. Comparatively, 0.1% of Hepion Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Histogen has a beta of 1.19, indicating that its stock price is 19% more volatile than the S&P 500. Comparatively, Hepion Pharmaceuticals has a beta of 1.69, indicating that its stock price is 69% more volatile than the S&P 500.

Histogen's return on equity of 0.00% beat Hepion Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
HistogenN/A N/A N/A
Hepion Pharmaceuticals N/A -812.56%-207.31%

In the previous week, Histogen's average media sentiment score of 0.00 equaled Hepion Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Histogen Neutral
Hepion Pharmaceuticals Neutral

Histogen has higher revenue and earnings than Hepion Pharmaceuticals. Hepion Pharmaceuticals is trading at a lower price-to-earnings ratio than Histogen, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Histogen$19K0.07-$10.62M-$2.810.00
Hepion PharmaceuticalsN/AN/A-$48.93M-$219.000.00

Summary

Histogen beats Hepion Pharmaceuticals on 7 of the 9 factors compared between the two stocks.

Get Histogen News Delivered to You Automatically

Sign up to receive the latest news and ratings for HSTO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HSTO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HSTO vs. The Competition

MetricHistogenPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$1K$776.92M$5.70B$9.50B
Dividend YieldN/A4.84%4.60%4.01%
P/E Ratio0.001.4028.1020.05
Price / Sales0.0725.35429.3789.38
Price / CashN/A19.5636.2258.56
Price / Book0.006.798.665.87
Net Income-$10.62M-$4.32M$3.25B$258.55M
7 Day PerformanceN/A1.15%4.22%3.73%
1 Month PerformanceN/A3.76%10.51%11.75%
1 Year PerformanceN/A9.52%34.40%18.03%

Histogen Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HSTO
Histogen
N/A$0.00
flat
N/A-99.9%$1K$19K0.0020
HEPA
Hepion Pharmaceuticals
0.1279 of 5 stars
$0.05
-6.4%
N/A-99.9%$528KN/A-0.0120Gap Up
BPTSY
Biophytis
N/A$1.33
-8.3%
N/AN/A$467KN/A0.0030Gap Down
VRPX
Virpax Pharmaceuticals
N/A$0.36
-2.5%
$75.00
+20,675.6%
-99.9%$448KN/A0.007Gap Down
VIRX
Viracta Therapeutics
2.567 of 5 stars
$0.01
-5.0%
$1.75
+18,129.2%
N/A$382KN/A-0.0120High Trading Volume
NCNA
NuCana
3.3263 of 5 stars
$0.05
+9.4%
$25.00
+49,700.8%
-98.3%$280KN/A-0.0130Gap Up
High Trading Volume
BON
Bon Natural Life
0.6411 of 5 stars
$1.48
-3.3%
N/AN/A$260K$23.84M0.00100Gap Up
CAPS
Capstone Therapeutics
N/A$1.51
-5.0%
N/AN/A$251K$43.42M0.0038
MYMD
MyMD Pharmaceuticals
N/A$0.10
-6.3%
N/A-92.9%$242KN/A0.006Gap Down
High Trading Volume
VINC
Vincerx Pharma
2.4883 of 5 stars
$0.04
-7.5%
$40.00
+92,923.3%
-99.6%$225KN/A0.0060Gap Up
UPC
Universe Pharmaceuticals
N/A$3.72
-2.9%
N/A-99.8%$160K$19.29M0.00220

Related Companies and Tools


This page (NASDAQ:HSTO) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners